Health Care & Life Sciences » Pharmaceuticals | PharmaRoth Labs Inc.

PharmaRoth Labs Inc. | Cash Flow

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
426.70
291.00
370.00
232.80
91.50
Depreciation, Depletion & Amortization
2.10
0.50
-
-
-
Other Funds
-
-
20.00
-
-
Funds from Operations
251.50
144.60
135.60
109.50
84.50
Changes in Working Capital
129.70
70.20
104.60
23.90
66.90
Net Operating Cash Flow
121.70
214.80
31.00
85.60
17.60
Net Financing Cash Flow
120.50
220.00
26.00
85.50
18.00
Net Change in Cash
1.20
5.20
5.00
0.10
0.40
Free Cash Flow
121.70
214.80
31.00
85.60
17.60
Change in Capital Stock
120.50
220.00
6.00
85.50
18.00

About PharmaRoth Labs

View Profile
Address
10080 West Alta Drive
Las Vegas Nevada 89145
United States
Employees -
Website http://www.pharmaroth.com
Updated 07/08/2019
PharmaRoth Labs, Inc. focuses on diabetes prevention and treatments. It holds the intellectual property rights related to the production, marketing and distribution of Sucanon, a oral treatment for type II diabetes. The company was founded on December 11, 2000 and is headquartered in Las Vegas, NV.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.